NEW TREATMENT FOR PROSTATE CANCER

That this House welcomes reports of the success of early trials of Abiraterone in treating an aggressive and often fatal form of prostate cancer; notes that eight out of 10 patients who have advanced prostate cancer may see their tumours shrink and be relieved of pain simply by taking a daily pill; further notes that full trials will be undertaken and that the drug may be generally available in three or four years; further notes that this drug, if it proves its potential during full trials, could help 10,000 men who die from aggressive prostate cancer each year; and therefore calls on the Government to ensure all possible support is given to accelerate the trials and ensure that the drug is available at the earliest possible moment.